Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 May;71(5):1106–1110. doi: 10.1038/bjc.1995.214

Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer.

C C Yu 1, D A Levison 1, J A Dunn 1, L C Ward 1, M Demonakou 1, W H Allum 1, M T Hallisey 1
PMCID: PMC2033774  PMID: 7734309

Abstract

The second British Stomach Cancer Group trial was a prospective randomised controlled trial of adjuvant radiotherapy or cytotoxic chemotherapy after gastrectomy for adenocarcinoma. It recruited between 1981 and 1986. No survival advantage has been demonstrated for the patients receiving either type of adjuvant therapy compared with those undergoing surgery alone. We report on 436 patients randomised into the trial together with 203 patients, who did not fulfil the trial criteria, referred to the trial. A univariate (log-rank) analysis of pathological factors obtained from the local referring centres showed that tumour size, macroscopic type, number os sites involved, depth of invasion, involvement of resection lines and lymph nodes and histological grade were significant determinants of survival. Histological review by two experienced histopathologists found that the Lauren classification and histological grade, but not the Ming classification, were significant prognostic factors. The degree of lymphocytic and eosinophilic infiltration and presence of dysplasia assessed by one of the pathologists showed a significant correlation with survival. However, inter-observer correlation for these histological parameters and grade was poor. Multivariate analysis identified only depth of invasion, resection line and nodal involvement as significant independent pathological variables influencing survival. This study confirms the need for expert preparation of the resected specimen to obtain the important information on depth of invasion and nodal status and also reveals some variation in histological assessment, particularly grading, in gastric carcinoma.

Full text

PDF
1106

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akoh J. A., Sedgwick D. M., Macintyre I. M. Improving results in the treatment of gastric cancer: an 11-year audit. Br J Surg. 1991 Mar;78(3):349–351. doi: 10.1002/bjs.1800780325. [DOI] [PubMed] [Google Scholar]
  2. Allum W. H., Hallissey M. T., Ward L. C., Hockey M. S. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. Br J Cancer. 1989 Nov;60(5):739–744. doi: 10.1038/bjc.1989.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arveux P., Faivre J., Boutron M. C., Piard F., Dusserre-Guion L., Monnet E., Hillon P. Prognosis of gastric carcinoma after curative surgery. A population-based study using multivariate crude and relative survival analysis. Dig Dis Sci. 1992 May;37(5):757–763. doi: 10.1007/BF01296435. [DOI] [PubMed] [Google Scholar]
  4. Baba H., Korenaga D., Okamura T., Saito A., Sugimachi K. Prognostic factors in gastric cancer with serosal invasion. Univariate and multivariate analyses. Arch Surg. 1989 Sep;124(9):1061–1064. doi: 10.1001/archsurg.1989.01410090071015. [DOI] [PubMed] [Google Scholar]
  5. Bozzetti F., Bonfanti G., Morabito A., Bufalino R., Menotti V., Andreola S., Doci R., Gennari L. A multifactorial approach for the prognosis of patients with carcinoma of the stomach after curative resection. Surg Gynecol Obstet. 1986 Mar;162(3):229–234. [PubMed] [Google Scholar]
  6. Caygill C., Day D. W., Hill M. J. The histopathology of gastric cancer in rural and urban areas of North Wales. Br J Cancer. 1983 Oct;48(4):603–605. doi: 10.1038/bjc.1983.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Davessar K., Pezzullo J. C., Kessimian N., Hale J. H., Jauregui H. O. Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol. 1990 Mar;21(3):325–332. doi: 10.1016/0046-8177(90)90234-v. [DOI] [PubMed] [Google Scholar]
  8. Elias D., Lasser P. H., Bognel C., Nadal J. M., Rahal K., Pineda R., Rougier P. Adénocarcinomes gastriques réséqués curativement. Analyse multifactorielle des facteurs pronostiques. Gastroenterol Clin Biol. 1988 Oct;12(10):729–735. [PubMed] [Google Scholar]
  9. Elster K., Carson W., Wild A., Thomasko A. Evaluation of histological classification in early gastric cancer (an analysis of 300 cases). Endoscopy. 1979 Sep;11(3):203–206. doi: 10.1055/s-0028-1098353. [DOI] [PubMed] [Google Scholar]
  10. Hallissey M. T., Dunn J. A., Ward L. C., Allum W. H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 1994 May 28;343(8909):1309–1312. doi: 10.1016/s0140-6736(94)92464-3. [DOI] [PubMed] [Google Scholar]
  11. Hallissey M. T., Jewkes A. J., Dunn J. A., Ward L., Fielding J. W. Resection-line involvement in gastric cancer: a continuing problem. Br J Surg. 1993 Nov;80(11):1418–1420. doi: 10.1002/bjs.1800801121. [DOI] [PubMed] [Google Scholar]
  12. Haugstvedt T. K., Viste A., Eide G. E., Söreide O. Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial. Br J Surg. 1993 Apr;80(4):475–478. doi: 10.1002/bjs.1800800423. [DOI] [PubMed] [Google Scholar]
  13. LAUREN P. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31–49. doi: 10.1111/apm.1965.64.1.31. [DOI] [PubMed] [Google Scholar]
  14. Ming S. C. Gastric carcinoma. A pathobiological classification. Cancer. 1977 Jun;39(6):2475–2485. doi: 10.1002/1097-0142(197706)39:6<2475::aid-cncr2820390626>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  15. Nakamura K., Ueyama T., Yao T., Xuan Z. X., Ambe K., Adachi Y., Yakeishi Y., Matsukuma A., Enjoji M. Pathology and prognosis of gastric carcinoma. Findings in 10,000 patients who underwent primary gastrectomy. Cancer. 1992 Sep 1;70(5):1030–1037. doi: 10.1002/1097-0142(19920901)70:5<1030::aid-cncr2820700504>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  16. Okusa T., Nakane Y., Boku T., Takada H., Yamamura M., Hioki K., Yamamoto M. Quantitative analysis of nodal involvement with respect to survival rate after curative gastrectomy for carcinoma. Surg Gynecol Obstet. 1990 Jun;170(6):488–494. [PubMed] [Google Scholar]
  17. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Ribeiro M. M., Sarmento J. A., Sobrinho Simões M. A., Bastos J. Prognostic significance of Lauren and Ming classifications and other pathologic parameters in gastric carcinoma. Cancer. 1981 Feb 15;47(4):780–784. doi: 10.1002/1097-0142(19810215)47:4<780::aid-cncr2820470424>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  19. Søreide O., Lillestøl J., Viste A., Bjerkeset T. Factors influencing survival in patients with cancer of the stomach. A multivariate analysis. Acta Chir Scand. 1982;148(4):367–372. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES